Imidacloprid; Pesticide Tolerances for Emergency Exemptions

FederalRegulations

Ask Donna

How this section applies to your facts.

Federal Register › Vol. 64 › 64 FR 3037

This text was captured on Sep 30, 2026. It is a snapshot, not a live feed, so check the official code before relying on it.

Text

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[OPP-300771; FRL 6051-6]

RIN 2070-AB78

Imidacloprid; Pesticide Tolerances for Emergency Exemptions

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This regulation establishes time-limited tolerances for

residues of imidacloprid in or on Legume Vegetables (Crop Group 6, 40

CFR 180.41(c)(6)) and Strawberries. This action is in response to EPA's

granting of emergency exemptions under section 18 of the Federal

Insecticide, Fungicide, and Rodenticide Act authorizing use of the

pesticide on legumes and strawberries. This regulation establishes

maximum permissible levels for residues of imidacloprid in these food

commodities pursuant to section 408(l)(6) of the Federal Food, Drug,

and Cosmetic Act, as amended by the Food Quality Protection Act of

1996. The tolerances will expire and are revoked on June 30, 2000.

DATES: This regulation is effective January 20, 1999. Objections and

requests for hearings must be received by EPA on or before March 22,

1999.

ADDRESSES: Written objections and hearing requests, identified by the

docket control number, [OPP-300771], must be submitted to: Hearing

Clerk (1900), Environmental Protection Agency, Rm. M3708, 401 M St.,

SW., Washington, DC 20460. Fees accompanying objections and hearing

requests shall be labeled ``Tolerance Petition Fees'' and forwarded to:

EPA Headquarters Accounting Operations Branch, OPP (Tolerance Fees),

P.O. Box 360277M, Pittsburgh, PA 15251. A copy of any objections and

hearing requests filed with the Hearing Clerk identified by the docket

control number, [OPP-300771], must also be submitted to: Public

Information and Records Integrity Branch, Information Resources and

Services Division (7502C), Office of Pesticide Programs, Environmental

Protection Agency, 401 M St., SW., Washington, DC 20460. In person,

bring a copy of objections and hearing requests to Rm. 119, CM #2, 1921

Jefferson Davis Hwy., Arlington, VA.

A copy of objections and hearing requests filed with the Hearing

Clerk may also be submitted electronically by sending electronic mail

(e-mail) to: [email protected]. Copies of objections and

hearing requests must be submitted as an ASCII file avoiding the use of

special characters and any form of encryption. Copies of objections and

hearing requests will also be accepted on disks in WordPerfect 5.1/6.1

or ASCII file format. All copies of objections and hearing requests in

electronic form must be identified by the docket control number [OPP-

300771]. No Confidential Business Information (CBI) should be submitted

through e-mail. Electronic copies of objections and hearing requests on

this rule may be filed online at many Federal Depository Libraries.

FOR FURTHER INFORMATION CONTACT: By mail: Andrea Beard, Registration

Division (7505C), Office of Pesticide Programs, Environmental

Protection Agency, 401 M St., SW., Washington, DC 20460. Office

location, telephone number, and e-mail address: Crystal Mall #2, 1921

Jefferson Davis Hwy., Arlington, VA, (703) 308-9356; e-mail:

[email protected].

SUPPLEMENTARY INFORMATION: EPA, on its own initiative, pursuant to

section 408(e) and (l)(6) of the Federal Food, Drug, and Cosmetic Act

(FFDCA), 21 U.S.C. 346a(e) and (l)(6), is establishing a tolerance for

residues of the insecticide imidacloprid (1-[(6-chloro-3-

pyridinyl)methyl]-N-nitro-2-imidazolidinimine), in or on legume

vegetables and strawberries, at 1.0 and 0.1 part per million (ppm),

respectively. These tolerances will expire and are revoked on 6/30/00.

EPA will publish a document in the Federal Register to remove the

revoked tolerances from the Code of Federal Regulations.

I. Background and Statutory Authority

The Food Quality Protection Act of 1996 (FQPA) (Pub. L. 104-170)

was signed into law August 3, 1996. FQPA amends both the Federal Food,

Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 301 et seq., and the Federal

Insecticide, Fungicide, and Rodenticide Act (FIFRA), 7 U.S.C. 136 et

seq. The FQPA amendments went into effect immediately. Among other

things, FQPA amends FFDCA to bring all EPA pesticide tolerance-setting

activities under a new section 408 with a new safety standard and new

procedures. These activities are described below and discussed in

greater detail in the final rule establishing the time-limited

tolerance associated with the emergency exemption for use of

propiconazole on sorghum (61 FR 58135, November 13, 1996) (FRL-5572-9).

New section 408(b)(2)(A)(i) of the FFDCA allows EPA to establish a

tolerance (the legal limit for a pesticide chemical residue in or on a

food) only if EPA determines that the tolerance is ``safe.'' Section

408(b)(2)(A)(ii) defines ``safe'' to mean that ``there is a reasonable

certainty that no harm will result from aggregate exposure to the

pesticide chemical residue, including all anticipated dietary exposures

and all other exposures for which there is reliable information.'' This

includes exposure through drinking water and in residential settings,

but does not include occupational exposure. Section 408(b)(2)(C)

requires EPA to give special consideration to exposure of infants and

children to the pesticide chemical residue in establishing a tolerance

and to ``ensure that there is a reasonable certainty that no harm will

result to infants and children from aggregate exposure to the pesticide

chemical residue.''

Section 18 of FIFRA authorizes EPA to exempt any Federal or State

agency from any provision of FIFRA, if EPA determines that ``emergency

conditions exist which require such exemption.'' This provision was not

amended by FQPA. EPA has established regulations governing such

emergency exemptions in 40 CFR part 166.

Section 408(l)(6) of the FFDCA requires EPA to establish a time-

limited tolerance or exemption from the requirement for a tolerance for

pesticide chemical residues in food that will result from the use of a

pesticide under an emergency exemption granted by EPA under section 18

of FIFRA. Such tolerances can be established without providing notice

or period for public comment.

Because decisions on section 18-related tolerances must proceed

before EPA reaches closure on several policy issues relating to

interpretation and implementation of the FQPA, EPA does not intend for

its actions on such tolerance to set binding precedents for the

application of section 408 and the new safety standard to other

tolerances and exemptions.

II. Emergency Exemption for Imidacloprid on Legume Vegetables and

Strawberries and FFDCA Tolerances

The State of Florida requested a specific exemption for use of

imidacloprid on legume vegetables to control the silverleaf whitefly.

The state of California also requested a specific exemption for use of

imidacloprid on strawberries to control the silverleaf whitefly. Both

Florida and California stated that an emergency situation is present

due to this recently introduced pest, its devastating effects on many

fruit and vegetable crops, and its resistance to registered

alternatives. The Applicants state that this pest can have devastating

effects on growers' production and revenue. EPA has authorized under

FIFRA section 18 the use of imidacloprid on Legume Vegetables and

Strawberries for control of silverleaf whitefly in Florida and

California, respectively. After having reviewed the submissions, EPA

concurs that emergency conditions exist for these states.

As part of its assessment of these emergency exemptions, EPA

assessed the potential risks presented by residues of imidacloprid in

or on legume vegetables and strawberries. In doing so, EPA considered

the new safety standard in FFDCA section 408(b)(2), and EPA decided

that the necessary tolerance under FFDCA section 408(l)(6) would be

consistent with the new safety standard and with FIFRA section 18.

Consistent with the need to move quickly on the emergency exemptions in

order to address urgent non-routine situations and to ensure that the

resulting food is safe and lawful, EPA is issuing these tolerances

without notice and opportunity for public comment under section 408(e),

as provided in section 408(l)(6). Although these tolerances will expire

and are revoked on 6/30/00, under FFDCA section 408(l)(5), residues of

the pesticide not in excess of the amounts specified in the tolerances

remaining in or on legume vegetables and strawberries after that date

will not be unlawful, provided the pesticide is applied in a manner

that was lawful under FIFRA, and the residues do not exceed a level

that was authorized by these tolerances at the time of that

application. EPA will take action to revoke these tolerances earlier if

any experience with, scientific data on, or other relevant information

on this pesticide indicate that the residues are not safe.

Because these tolerances are being approved under emergency

conditions EPA has not made any decisions about whether imidacloprid

meets EPA's registration requirements for use on legume vegetables and

strawberries or whether permanent tolerances for these uses would be

appropriate. Under these circumstances, EPA does not believe that these

tolerances serve as a basis for registration of imidacloprid by a State

for special local needs under FIFRA section 24(c). Nor do these

tolerances serve as the basis for any State other than Florida or

California to use this pesticide on the respective crops under section

18 of FIFRA without following all provisions of section 18 as

identified in 40 CFR part 166. For additional information regarding the

emergency exemptions for imidacloprid, contact the Agency's

Registration Division at the address provided above.

III. Aggregate Risk Assessment and Determination of Safety

EPA performs a number of analyses to determine the risks from

aggregate exposure to pesticide residues. For further discussion of the

regulatory requirements of section 408 and a complete description of

the risk assessment process, see the Final Rule on Bifenthrin Pesticide

Tolerances (62 FR 62961, November 26, 1997) (FRL-5754-7).

Consistent with section 408(b)(2)(D), EPA has reviewed the

available scientific data and other relevant information in support of

this action, EPA has sufficient data to assess the hazards of

imidacloprid and to make a determination on aggregate exposure,

consistent with section 408(b)(2), for time-limited tolerances for

residues of imidacloprid and its metabolites containing the 6-

chloropyridinyl moiety, all expressed as parent, on legume vegetables

and strawberries at 1.0 and 0.1 ppm, respectively. EPA's assessment of

the dietary exposures and risks associated with establishing the

tolerances follows.

A. Toxicological Profile

EPA has evaluated the available toxicity data and considered its

validity, completeness, and reliability as well as the relationship of

the results of the studies to human risk. EPA has also considered

available information concerning the variability of the sensitivities

of major identifiable subgroups of consumers, including infants and

children. The nature of the toxic effects caused by imidacloprid are

discussed below.

1. Acute toxicity. Based on the available acute toxicity data, OPP

has determined that the lowest observed effect level (LOEL) of 42

milligrams per kilogram body weight per day (mg/kg/bwt/day) from the

neurotoxicity study in rats should be used to assess risk from acute

toxicity. There was no observed adverse effect level (NOAEL) in the

study. Decreased motor activity in female rats was observed at the

LOEL. Using the uncertainty factors (UFs) of 10X for inter- and 10X for

intra-species variations, the acute Reference Dose (RfD) is 0.42 mg/kg/

day. This risk assessment is required for all population subgroups.

2. Short - and intermediate - term toxicity. OPP has determined

that available data do not demonstrate that imidacloprid has dermal or

inhalation toxicity potential. Therefore, short-term or intermediate-

term dermal and inhalation risk assessments, for occupational and

residential exposure scenarios, are not required. However, a short-term

aggregate risk assessment (oral exposure) is required for hand-to-mouth

residential exposure, and the acute toxicological endpoint, as

described above, is used for this risk assessment. Incorporating the 3X

uncertainty factor, as described below, an MOE of 300 or greater would

be acceptable.

3. Chronic toxicity. EPA had established the RfD for imidacloprid

at 0.057 mg/kg/day. This RfD is based on a standard uncertainty factor

(UF) of 100, and the NOAEL of 5.7 mg/kg/day from a combined chronic

toxicity/carcinogenicity study in rats, which demonstrated increased

number of thyroid lesions in male rats and decreased body weight gains

in female rats. For chronic dietary risk assessment, the Agency

determined that the FQPA uncertainty factor could be reduced to 3X and

should be applied to all population subgroups. This determination is

based on the weight-of-the-evidence considerations relating to

potential sensitivity and completeness of the data, specifically, in

regard to developmental neurotoxicity. This determination is further

explained below under section III(D)(v) of this document. Because a

developmental neurotoxicity study potentially relates to both acute and

chronic effects in both the mother and the fetus, the 3X UF for FQPA is

being applied for all population subgroups, and both acute and chronic

risk. Therefore, for the purposes of this risk assessment, dietary

exposure must not be above 33.3% of the RfD, to make the finding of

reasonable certainty of no harm.

4. Carcinogenicity. Using its Guidelines for Carcinogen Risk

Assessment published September 24, 1986 (51 FR 33992), EPA has

classified imidacloprid as a ``Group E'' chemical (no evidence of

carcinogenicity for

humans) based on the results of carcinogenicity studies in two species.

The doses tested are adequate for identifying a cancer risk, and thus,

a cancer risk assessment is not required.

B. Exposures and Risks

1. From food and feed uses. Tolerances have been established (40

CFR 180.472) for the residues of imidacloprid (1-[(6-chloro-3-

pyridinyl)methyl]-N-nitro-2-imidazolidinimine) and its metabolites, in

or on a variety of raw agricultural commodities, ranging from 0.02 ppm

in/on eggs to 15 ppm in/on raisin waste. Existing meat/milk/poultry

tolerances are adequate to cover any secondary residues which may occur

as a result of feeding legume products; secondary residues are not

expected to occur from strawberries, as they are not a significant

livestock feed item. Risk assessments were conducted by EPA to assess

dietary exposures and risks from imidacloprid as follows:

i. Acute exposure and risk. Acute dietary risk assessments are

performed for a food-use pesticide if a toxicological study has

indicated the possibility of an effect of concern occurring as a result

of a one day or single exposure. An acute dietary risk assessment for

imidacloprid is required for all population subgroups. The acute

dietary risk assessment used the Theoretical Maximum Residue

Contribution (TMRC, tolerance level residues and 100% crop treated);

the tolerances used for legumes and strawberries were 1.0 and 0.1 ppm,

respectively. The Novigen Dietary Exposure Evaluation Model (DEEM)

analysis was used and this analysis evaluates individual food

consumption as reported by respondents in the USDA Continuing Surveys

of Food Intake by Individuals conducted in 1989 through 1992. The model

accumulates exposure to the chemical for each commodity and expresses

risk as a function of dietary exposure. Resulting exposure values at

the 99th percentile and percentage of the acute RfD are shown below.

Values for the 99th percentile are considered to be conservative as OPP

policy dictates exposure estimates from as low as the 95th percentile

may be utilized for risk estimates from acute DEEM runs. Thus, these

results are viewed as conservative estimates, and refinement using

anticipated residue values and percent crop treated information, in

conjunction with a Monte Carlo analysis, would result in lower

estimates of acute dietary exposure and risk. The subgroups listed in

the table below are the U.S. population, and those for infants and

children. There are no other subgroups (adult) for which the percentage

of the Acute RfD occupied is greater than that occupied by the subgroup

U.S. Population (48 states).

------------------------------------------------------------------------

Exposure @

99th

Population Subgroup Percentile Percent

(mg/kg bwt/ Acute RfD

day)

------------------------------------------------------------------------

U.S. Population (48 states)................... 0.051 12%

Infants (g/L) parts per billion (ppb),

respectively. These estimated concentrations of imidacloprid in surface

and ground water were based upon an application rate of 0.5 lbs active

ingredient/ Acre/year (ai/A/year). For purposes of risk assessment, the

estimated maximum concentration of 4.1 ppb was used. The calculated

acute DWLOCs ranged from 440 ppb for Nursing Infants g/L is used for comparison to the back-

calculated human health DWLOCs for the short-term endpoint. The DWLOC

for short-term exposure for the population subgroup of concern,

Children 1 - 6 yrs. old was calculated to be 600 ppb.

iii. Chronic exposure. EPA used estimated concentrations of

imidacloprid in surface and ground water for chronic exposure analysis

of 0.1 and 1.1 g/L (ppb), respectively. These estimated

concentrations of imidacloprid in surface and ground water are based

upon an application rate of 0.5 lbs ai/A/year. The calculated chronic

DWLOCs ranged from 100 ppb for Children 1 - 6 yrs. old, to 540 ppb for

the U.S. population - Males.

iv. Conclusions concerning residues in drinking water. The

estimated concentrations of imidacloprid in surface and ground water

are considerably less than the Agency's DWLOCs for imidacloprid in

drinking water as a contribution to acute, short-term, and chronic

aggregate exposure. Therefore, taking into account the present uses,

including those under emergency exemptions, EPA concludes with

reasonable certainty that residues of imidacloprid in drinking water

would not result in an unacceptable estimate of acute, short-term, or

chronic aggregate human health risk at this time.

3. From non-dietary exposure. Imidacloprid is currently registered

for use on the following residential non-food sites: ornamentals (e.g.,

flowering and foliage plants, ground covers, turf, lawns, et al.),

tobacco, golf courses, walkways, recreational areas, bathrooms,

household or domestic dwellings (indoor/outdoor), cats/dogs, and wood

protection treatment to buildings. Available data do not demonstrate

that imidacloprid has either dermal or inhalation toxicity potential,

therefore, occupational/residential risk assessments are not required.

Since data show no toxicity from short term exposure via the dermal or

inhalation route, the Agency feels there is no contribution to toxicity

from these routes of exposure, and no increase in aggregate risk is

anticipated from this exposure. However, oral exposure due to the

registered residential uses may result, in particular for Children (1-6

years old). Post-application exposure scenarios for children include:

incidental non-dietary ingestion of residues on lawn from hand-to-mouth

transfer; ingestion of pesticide-treated turfgrass; incidental

ingestion of soil from treated gardens; and incidental ingestion of

pesticide residues on pets from hand-to-mouth transfer. These exposures

are considered to be short-term oral exposures, and thus a residential

short-term risk assessment via the oral route is required.

Incidental ingestion of pesticide residues on pets from hand-to

mouth transfer may occur during the same period as the exposures from

the turf and home garden uses. However, children's exposures from pet

and turf uses are not expected to both occur at the high-end level.

Therefore, these exposures were considered in separate estimates of

risk. For Children (1 - 6 years), the residential exposure from the

home garden and turf uses was estimated to be 0.072 mg/kg bwt/day and

the residential exposure from the pet use was estimated to be 0.058 mg/

kg bwt/day.

4. Cumulative exposure to substances with common mechanism of

toxicity. Section 408(b)(2)(D)(v) requires that, when considering

whether to establish, modify, or revoke a tolerance, the Agency

consider ``available information'' concerning the cumulative effects of

a particular pesticide's residues and ``other substances that have a

common mechanism of toxicity.'' An explanation of the current Agency

approach to assessment of pesticides with a common mechanism of

toxicity may be found in the Final Rule in Bifenthrin Pesticide

Tolerances (Federal Register, November 26, 1997, 62 FR 62961-62970).

EPA does not have, at this time, available data to determine

whether imidacloprid has a common mechanism of toxicity with other

substances or how to include this pesticide in a cumulative risk

assessment. Unlike other pesticides for which EPA has followed a

cumulative risk approach based on a common mechanism of toxicity,

imidacloprid does not appear to produce a toxic metabolite produced by

other substances. For the purposes of this tolerance action, therefore,

EPA has not assumed that imidacloprid has a common mechanism of

toxicity with other substances. Imidacloprid is the sole member to date

of the new chloronicotinyl class of pesticides.

C. Aggregate Risks and Determination of Safety for U.S. Population

1. Acute risk. Acute dietary risk was estimated using the

conservative TMRC assumptions, as explained above. There was no

refinement using anticipated residue values and percent crop-treated

information in conjunction with Monte Carlo analysis which would result

in much lower estimates of acute dietary exposure. For the most highly

exposed subgroup, (Nursing Infants g/L is used for comparison to the human health DWLOCs for the

acute endpoint. Despite the potential for exposure to imidacloprid in

drinking water, after calculating DWLOCs and comparing them to these

conservative model estimates of concentrations of imidacloprid for

surface and ground water, EPA does not expect the aggregate exposure to

exceed 33.3% of the acute RfD. Under current guidelines, non-dietary

uses of imidacloprid do not constitute an acute exposure scenario.

Therefore, EPA concludes that there is a reasonable certainty that no

harm will

result to infants, children, or adults from acute aggregate (food and

water) exposure to imidacloprid residues.

Dermal and inhalation exposure endpoints were not selected due to

the demonstrated absence of toxicity; thus, there is no residential

component for assessing chronic aggregate exposure and risk.

The refined assumptions described above were used, and thus this

risk assessment should be viewed as partially refined. Further

refinement using anticipated residue values and additional %CT

information would result in a lower estimate of chronic dietary

exposure. EPA has estimated that the chronic exposure to imidacloprid

from food for the most highly exposed adult population subgroup (Non-

Hispanic Other Than Black or White) will utilize 7.2% of the Chronic

RfD, and for the most highly exposed population subgroup that includes

children (Children, 1-6 years old), dietary exposure will utilize 15%

of the Chronic RfD, as shown previously. For imidacloprid, it was

determined that an acceptable chronic dietary exposure (food plus

water) of 33.3% or less of the Chronic RfD is needed to protect the

safety of all population subgroups (due to the FQPA 3-fold uncertainty

factor).

For purposes of chronic risk assessment, the estimated maximum

concentration for imidacloprid in surface and ground waters (which is

1.1 g/L) is used for comparison to the human health drinking

water levels of comparison (DWLOCs) for the chronic (non-cancer)

endpoint. Despite the potential for exposure to imidacloprid in

drinking water, after calculating DWLOCs and comparing them to these

conservative model estimates of concentrations of imidacloprid for

surface and ground water, EPA does not expect the aggregate exposure to

exceed 33.3% of the chronic RfD. Therefore, EPA concludes that there is

a reasonable certainty that no harm will result to infants, children,

or adults from chronic aggregate (food and water) exposure to

imidacloprid residues.

2. Short- and intermediate-term risk. Short- and intermediate-term

aggregate exposure takes into account chronic dietary food and water

(considered to be a background exposure level) plus indoor and outdoor

residential exposure. Dermal and inhalation short- and intermediate

term risk assessments are not required for imidacloprid as dermal and

inhalation exposure endpoints were not identified due to the

demonstrated absence of toxicity. Short- and intermediate-term oral

exposure are not expected for adult population subgroups. Thus, this

risk assessment is not required.

Since imidacloprid is registered for use on turf, home gardens and

pets. EPA has identified potential short-term oral exposures to

children for these uses. These exposures were considered in separate

estimates of risk. These risk estimates are discussed below in the

section on aggregate risks and determination of safety for infants and

children.

3. Aggregate cancer risk for U.S. population. Imidacloprid has been

classified as a Group E chemical, no evidence of carcinogenicity for

humans; therefore, a cancer risk assessment is not required.

4. Determination of safety. Based on these risk assessments, EPA

concludes that there is reasonable certainty that no harm will result

from aggregate exposure to imidacloprid residues.

D. Aggregate Risks and Determination of Safety for Infants and Children

1. Safety factor for infants and children--i. In general. In

assessing the potential for additional sensitivity of infants and

children to residues of imidacloprid, EPA considered data from

developmental toxicity studies in the rat and rabbit and a 2-generation

reproduction study in the rat. The developmental toxicity studies are

designed to evaluate adverse effects on the developing organism

resulting from maternal pesticide exposure during gestation.

Reproduction studies provide information relating to effects from

exposure to the pesticide on the reproductive capability of mating

animals and data on systemic toxicity.

FFDCA section 408 provides that EPA shall apply an additional

tenfold margin of safety for infants and children in the case of

threshold effects to account for pre-and post-natal toxicity and the

completeness of the database unless EPA determines that a different

margin of safety will be safe for infants and children. Margins of

safety are incorporated into EPA risk assessments either directly

through use of a MOE analysis or through using uncertainty (safety)

factors in calculating a dose level that poses no appreciable risk to

humans. EPA believes that reliable data support using the standard MOE

and uncertainty factor (usually 100 for combined inter- and intra-

species variability)) and not the additional tenfold MOE/uncertainty

factor when EPA has a complete data base under existing guidelines and

when the severity of the effect in infants or children or the potency

or unusual toxic properties of a compound do not raise concerns

regarding the adequacy of the standard MOE/safety factor.

ii. Developmental toxicity studies. In the rat developmental study,

the maternal (systemic) NOAEL was 30 mg/kg/day, based on decreased

weight gain at the LOEL of 100 mg/kg/day. The developmental (fetal)

NOAEL was 30 mg/kg/day based on increased wavy ribs at the LOEL of 100

mg/kg/day. In the rabbit developmental study, the maternal (systemic)

NOAEL was 24 mg/kg/day, based on decreased body weight, increased

resorptions and abortions, and death at the LOEL of 72 mg/kg/day. The

developmental (fetal) NOAEL was 24 mg/kg/day, based on decreased body

weight and increased skeletal anomalies at the LOEL of 72 mg/kg/day.

iii. Reproductive toxicity study. In a 2-generation reproductive

toxicity study, imidacloprid (95.3%) was administered to Wistar/Han

rats at dietary levels of 0, 100, 250, or 700 ppm (0, 7.3, 18.3, or

52.0 mg/kg/day for males and 0, 8.0, 20.5, or 57.4 mg/kg/day for

females). For parental/systemic/reproductive toxicity, the NOAEL was

250 ppm (18.3 mg/kg/day) and the LOEL was 750 ppm (52 mg/kg/day), based

on decreases in body weight in both sexes in both generations.

iv. Pre- and post-natal sensitivity. The developmental toxicity

data demonstrated no increased sensitivity of rats or rabbits to in

utero exposure to imidacloprid. In addition, the multi-generation

reproductive toxicity study data did not identify any increased

sensitivity of rats to in utero or postnatal exposure. Parental NOAELs

were lower or equivalent to developmental or offspring NOAELs. The

developmental toxicity studies are designed to evaluate adverse effects

on the developing organism resulting from maternal pesticide exposure

gestation. Reproduction studies provide information relating to effects

from exposure to the pesticide on the reproductive capability of mating

animals and data on systemic toxicity.

v. Conclusion. Although developmental toxicity studies showed no

increased sensitivity in fetuses as compared to maternal animals

following in utero exposures in rats and rabbits, no increased

sensitivity in pups as compared to adults was seen in the 2-generation

reproduction toxicity study in rats, and the toxicology data base is

complete as to core requirements, the Agency determined that the

additional safety factor for the protection of infants and children

will be retained but reduced to 3X based on the following weight-of-

the-evidence considerations

relating to potential sensitivity and completeness of the data:

a. There is concern for structure activity relationship.

Imidacloprid, a chloronicotinyl compound, is an analog to nicotine and

studies in the published literature suggests that nicotine, when

administered causes developmental toxicity, including functional

deficits, in animals and/or humans that are exposed in utero.

b. There is evidence that imidacloprid administration causes

neurotoxicity following a single oral dose in the acute study and

alterations in brain weight in rats in the 2-year carcinogenicity

study.

c. The concern for structure activity relationship along with the

evidence of neurotoxicity dictates the need for a developmental

neurotoxicity study for assessment of potential alterations on

functional development.

Because a developmental neurotoxicity study potentially relates to

both acute and chronic effects in both the mother and the fetus, the UF

for FQPA is being applied for all population subgroups, and for both

acute and chronic risk. Therefore, for the purposes of this risk

assessment, dietary exposure must not be above 33.3% of the RfD, to

make the finding of reasonable certainty of no harm.

2. Acute risk. More detail on the acute risk assessments are given

above. EPA used the conservative exposure assumptions described above,

and estimated acute exposure to imidacloprid from food will utilize 23%

of the acute RfD for the most highly exposed population subgroup that

includes children (Non-nursing Infants [email protected].

Electronic comments must be submitted as an ASCII file avoiding the

use of special characters and any form of encryption.

The official record for this rulemaking, as well as the public

version, as described above will be kept in paper form. Accordingly,

EPA will transfer any copies of objections and hearing requests

received electronically into printed, paper form as they are received

and will place the paper copies in the official rulemaking record which

will also include all comments submitted directly in writing. The

official rulemaking record is the paper record maintained at the

Virginia address in ``ADDRESSES'' at the beginning of this document.

VIII. Regulatory Assessment Requirements

A. Certain Acts and Executive Orders

This final rule establishes time-limited tolerances under FFDCA

section 408(d) in response to a petition submitted to the Agency. The

Office of Management and Budget (OMB) has exempted these types of

actions from review under Executive Order 12866, entitled Regulatory

Planning and Review (58 FR 51735, October 4, 1993).

This final rule does not contain any information collections subject

to OMB approval under the Paperwork Reduction Act (PRA), 44 U.S.C. 3501

et seq., or impose any enforceable duty or contain any unfunded mandate

as described under Title II of the Unfunded Mandates Reform Act of 1995

(UMRA) (Pub. L. 104-4). Nor does it require any prior consultation as

specified by Executive Order 12875, entitled Enhancing the

Intergovernmental Partnership (58 FR 58093, October 28, 1993), or

special considerations as required by Executive Order 12898, entitled

Federal Actions to Address Environmental Justice in Minority

Populations and Low-Income Populations (59 FR 7629, February 16, 1994),

or require OMB review in accordance with Executive Order 13045,

entitled Protection of Children from Environmental Health Risks and

Safety Risks (62 FR 19885, April 23, 1997).

In addition, since these tolerances and exemptions that are

established under FFDCA section 408 (l)(6), such as the tolerances in

this final rule, do not require the issuance of a proposed rule, the

requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et

seq.) do not apply. Nevertheless, the Agency has previously assessed

whether establishing tolerances, exemptions from tolerances, raising

tolerance levels or expanding exemptions might adversely impact small

entities and concluded, as a generic matter, that there is no adverse

economic impact. The factual basis for the Agency's generic

certification for tolerance actions published on May 4, 1981 (46 FR

24950), and was provided to the Chief Counsel for Advocacy of the Small

Business Administration.

B. Executive Order 12875

Under Executive Order 12875, entitled Enhancing the

Intergovernmental Partnership (58 FR 58093, October 28, 1993), EPA may

not issue a regulation that is not required by statute and that creates

a mandate upon a State, local, or tribal government, unless the Federal

government provides the funds necessary to pay the direct compliance

costs incurred by those governments. If the mandate is unfunded, EPA

must provide to OMB a description of the extent of EPA's prior

consultation with representatives of affected State, local, and tribal

governments, the nature of their concerns, copies of any written

communications from the governments, and a statement supporting the

need to issue the regulation. In addition, Executive Order 12875

requires EPA to develop an effective process permitting elected

officials and other representatives of State, local, and tribal

governments ``to provide meaningful and timely input in the development

of regulatory proposals containing significant unfunded mandates.''

Today's rule does not create an unfunded Federal mandate on State,

local, or tribal governments. The rule does not impose any enforceable

duties on these entities. Accordingly, the requirements of section 1(a)

of Executive Order 12875 do not apply to this rule.

C. Executive Order 13084

Under Executive Order 13084, entitled Consultation and Coordination

with Indian Tribal Governments (63 FR 27655, May 19,1998), EPA may not

issue a regulation that is not required by statute, that significantly

or uniquely affects the communities of Indian tribal governments, and

that imposes substantial direct compliance costs on those communities,

unless the Federal government provides the funds necessary to pay the

direct compliance costs incurred by the tribal governments. If the

mandate is unfunded, EPA must provide to OMB, in a separately

identified section of the preamble to the rule, a description of the

extent of EPA's prior consultation with representatives of affected

tribal governments, a summary of the nature of their concerns, and a

statement supporting the need to issue the regulation. In addition,

Executive Order 13084 requires EPA to develop an effective process

permitting elected officials and other representatives of Indian tribal

governments ``to provide meaningful and timely input in the development

of regulatory policies on matters that significantly or uniquely affect

their communities.''

Today's rule does not significantly or uniquely affect the

communities of Indian tribal governments. This action does not involve

or impose any requirements that affect Indian tribes. Accordingly, the

requirements of section 3(b) of Executive Order 13084 do not apply to

this rule.

IX. Submission to Congress and the Comptroller General

The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the

Small Business Regulatory Enforcement Fairness Act of 1996, generally

provides that before a rule may take effect, the agency promulgating

the rule must submit a rule report, which includes a copy of the rule,

to each House of the Congress and to the Comptroller General of the

United States. EPA will submit a report containing this rule and other

required information to the U.S. Senate, the U.S. House of

Representatives, and the Comptroller General of the United States prior

to publication of the rule in the Federal Register. This rule is not a

``major rule'' as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

Environmental protection, Administrative practice and procedure,

Agricultural commodities, Pesticides and pests, Reporting and

recordkeeping requirements.

Dated: December 23, 1998.

James Jones,

Director, Registration Division, Office of Pesticide Programs.

Therefore, 40 CFR chapter I is amended as follows:

PART 180 -- [AMENDED]

1. The authority citation for part 180 continues to read as

follows:

Authority: 21 U.S.C. 346a and 371.

2. In Sec. 180.472, by alphabetically adding the following

commodities to the table in paragraph (b) to read as follows:

Sec. 180.472 Imidacloprid; tolerances for residues.

* * * * *

(b) * * *

------------------------------------------------------------------------

Expiration/

Commodity Parts per million Revocation Date

------------------------------------------------------------------------

* * * * *

Legume Vegetables............... 0.1 6/30/00

Strawberry...................... 1.0 6/30/00

* * * * *

------------------------------------------------------------------------

* * * * *

[FR Doc. 99-1253 Filed 1-19-99; 8:45 am]

BILLING CODE 6560-50-F

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.

Imidacloprid; Pesticide Tolerances for Emergency Exemptions · 64 FR 3037 | Frix